Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Common Factors in Neurodegeneration: A Meta-Study Revealing Shared Patterns on a Multi-Omics Scale
Nicolas Ruffini, Susanne Klingenberg, Susann Schweiger, et al.
Cells (2020) Vol. 9, Iss. 12, pp. 2642-2642
Open Access | Times Cited: 47

Showing 1-25 of 47 citing articles:

Recent progresses in exosome-based systems for targeted drug delivery to the brain
Santosh Bashyal, Thapa Chhitij, Sang Kil Lee
Journal of Controlled Release (2022) Vol. 348, pp. 723-744
Closed Access | Times Cited: 82
Identification of Therapeutic Targets for Amyotrophic Lateral Sclerosis Using PandaOmics – An AI-Enabled Biological Target Discovery Platform
Frank W. Pun, Bonnie Hei Man Liu, Xi Long, et al.
Frontiers in Aging Neuroscience (2022) Vol. 14
Open Access | Times Cited: 69
Niosomes for nose-to-brain delivery: A non-invasive versatile carrier system for drug delivery in neurodegenerative diseases
Alaa Raad Al Jayoush, Hatem A. F. M. Hassan, Hawraa Asiri, et al.
Journal of Drug Delivery Science and Technology (2023) Vol. 89, pp. 105007-105007
Closed Access | Times Cited: 28
The impact of air pollution on neurodegenerative diseases: a narrative review of current evidence
Nicholas Aderinto, Ayobami Ajagbe, Gbolahan Olatunji, et al.
The Egyptian Journal of Internal Medicine (2025) Vol. 37, Iss. 1
Open Access | Times Cited: 1
Cyanobacteria, Cyanotoxins, and Neurodegenerative Diseases: Dangerous Liaisons
Paola Sini, Thi Bang Chau Dang, Milena Fais, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 16, pp. 8726-8726
Open Access | Times Cited: 55
A Systematic Review of Transcriptional Dysregulation in Huntington’s Disease Studied by RNA Sequencing
Bimala Malla, Xuánzōng Guō, Gökçe Senger, et al.
Frontiers in Genetics (2021) Vol. 12
Open Access | Times Cited: 44
Role of siRNA-based nanocarriers for the treatment of neurodegenerative diseases
Neeraj Mishra, Sumel Ashique, Ashish Garg, et al.
Drug Discovery Today (2022) Vol. 27, Iss. 5, pp. 1431-1440
Closed Access | Times Cited: 30
Genetic risk factor clustering within and across neurodegenerative diseases
Mathew J. Koretsky, Chelsea X. Alvarado, Mary B. Makarious, et al.
Brain (2023) Vol. 146, Iss. 11, pp. 4486-4494
Open Access | Times Cited: 19
Mass Spectrometry for Neurobiomarker Discovery: The Relevance of Post-Translational Modifications
Rita Azevedo, Chloé Jacquemin, Nicolas Villain, et al.
Cells (2022) Vol. 11, Iss. 8, pp. 1279-1279
Open Access | Times Cited: 26
Traumatic brain injury induces TDP-43 mislocalization and neurodegenerative effects in tissue distal to the primary injury site in a non-transgenic mouse
George R. Bjorklund, Jennifer T. Wong, David A. Brafman, et al.
Acta Neuropathologica Communications (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 13
Combined Metabolic Activators with Different NAD+ Precursors Improve Metabolic Functions in the Animal Models of Neurodegenerative Diseases
Özlem Altay, Hong Yang, Serkan Yıldırım, et al.
Biomedicines (2024) Vol. 12, Iss. 4, pp. 927-927
Open Access | Times Cited: 5
Omics Data and Their Integrative Analysis to Support Stratified Medicine in Neurodegenerative Diseases
Valentina La Cognata, Giovanna Morello, Sebastiano Cavallaro
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 9, pp. 4820-4820
Open Access | Times Cited: 29
Recent Advances in the Study of Na+/K+-ATPase in Neurodegenerative Diseases
Xiaoyan Zhang, Weithye Lee, Jin‐Song Bian
Cells (2022) Vol. 11, Iss. 24, pp. 4075-4075
Open Access | Times Cited: 21
Targeting calcium homeostasis and impaired inter-organelle crosstalk as a potential therapeutic approach in Parkinson's disease
Satinder Kaur, Abhishek Sehrawat, Sarabjit Mastana, et al.
Life Sciences (2023) Vol. 330, pp. 121995-121995
Closed Access | Times Cited: 11
Apoptosis-Mechanisms, Regulation in Pathology, and Therapeutic Potential
Irshad Ahmad Bhat, Aalim Maqsood Bhat, Sheikh Tasduq Abdullah
IntechOpen eBooks (2025)
Closed Access
Integrated transcriptomics of multiple sclerosis peripheral blood mononuclear cells explored potential biomarkers for the disease
Arman Mokaram Doust Delkhah
Biochemistry and Biophysics Reports (2025) Vol. 42, pp. 102022-102022
Closed Access
Neuroadaptation in neurodegenerative diseases: compensatory mechanisms and therapeutic approaches
Spandana Rajendra Kopalli, Tapan Behl, Lalji Baldaniya, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2025), pp. 111375-111375
Closed Access
The promise of multi-omics approaches to discover biological alterations with clinical relevance in Alzheimer’s disease
Christopher Clark, Miriam Rabl, Loı̈c Dayon, et al.
Frontiers in Aging Neuroscience (2022) Vol. 14
Open Access | Times Cited: 17
A comprehensive review on therapeutic application of mesenchymal stem cells in neuroregeneration
Shyamaladevi Babu, Madhan Krishnan, Arjunkumar Panneerselvam, et al.
Life Sciences (2023) Vol. 327, pp. 121785-121785
Closed Access | Times Cited: 9
Long‐term molecular differences between resilient and susceptible mice after a single traumatic exposure
Diego Pascual Cuadrado, Hristo Todorov, Raissa Lerner, et al.
British Journal of Pharmacology (2021) Vol. 179, Iss. 17, pp. 4161-4180
Open Access | Times Cited: 18
Mass spectrometry methods for analysis of extracellular matrix components in neurological diseases
Margaret Downs, Joseph Zaia, Manveen K. Sethi
Mass Spectrometry Reviews (2022) Vol. 42, Iss. 5, pp. 1848-1875
Closed Access | Times Cited: 10
Sensitive and Low-Bias Transcriptome Sequencing Using Agarose PCR
Ying Zhou, Erteng Jia, Yuqi Sheng, et al.
ACS Applied Materials & Interfaces (2022) Vol. 14, Iss. 17, pp. 19154-19167
Closed Access | Times Cited: 9
RETRACTED: Combined metabolic activators improve metabolic functions in the animal models of neurodegenerative diseases
Hasan Türkez, Özlem Altay, Serkan Yıldırım, et al.
Life Sciences (2022) Vol. 314, pp. 121325-121325
Open Access | Times Cited: 9
Therapeutic Potential of Nanomedicine in Management of Alzheimer’s Disease and Glioma
Firoz Anwar, Fahad A. Al‐Abbasi, Salma Naqvi, et al.
International Journal of Nanomedicine (2023) Vol. Volume 18, pp. 2737-2756
Open Access | Times Cited: 5
A Systematic Review of Extracellular Matrix-Related Alterations in Parkinson’s Disease
Mary Ann Chapman, Barbara A. Sorg
Brain Sciences (2024) Vol. 14, Iss. 6, pp. 522-522
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top